company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1596000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-103000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1493000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,49000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,367000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,157000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-920000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-920000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-906000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1419000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-103000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1316000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,239000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1024000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1024000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:57:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1024000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1932000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-129000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1803000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,106000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,62000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1564000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1564000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20300000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21810000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21810000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20246000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4202000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-51000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4151000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,752000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,659000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2658000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2658000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22772000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-20300000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2472000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2472000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-312000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4261000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-96000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4165000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,793000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,816000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2475000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2475000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-387000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-387000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-387000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-188000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-183000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-183000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3045000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4921000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-91000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4830000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,40000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,778000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-146000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4107000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4107000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-423000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-423000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-423000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:57:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4530000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4569000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-43000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4526000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,96000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1015000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-599000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3971000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3971000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3013000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3013000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1002000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6121000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,140000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6261000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1980000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1284000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2818000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2806000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-79000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-79000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50491000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50491000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50491000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47606000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7737000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,1076000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8813000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,50000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,127000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1959000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,564000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6113000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6125000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-426000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-426000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-426000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6542000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12953000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12953000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,70000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1835000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2957000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7961000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7961000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-435000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-435000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-435000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,612000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,612000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,612000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:43:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7784000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15414000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15414000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,131000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2403000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1980000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10821000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10821000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10873000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12873000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12873000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,88000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,135000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4095000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3799000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12354000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12354000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-977000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-977000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-977000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1079000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1079000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1079000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12252000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14043000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14043000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4416000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-167000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57811000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1673000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59484000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59484000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49690000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17538000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17538000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,139000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2969000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1397000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15713000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15713000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,958000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,958000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,958000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:43:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14812000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19011000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19011000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,142000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1080000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5188000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12476000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12476000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-278000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-278000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-278000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58941000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1350000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60291000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60291000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q2,2013-10-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47537000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19194000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19194000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,150000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,144000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1760000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2096000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19236000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19236000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-82000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-82000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-6000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,524000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,518000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,518000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q3,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18800000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20624000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20624000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,189000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,148000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3180000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4250000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12857000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12857000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1021000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1021000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1021000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,269000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,341000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,341000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2014.0,Q4,2013-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13537000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20570000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20570000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,152000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,151000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2551000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1953000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19669000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19669000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2878000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2878000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2878000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17119000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23107000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23107000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,154000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3022000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3941000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15819000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15819000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-203000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,241000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,128323000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3428000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,131751000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,131751000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115970000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22672000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22672000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,175000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,158000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2821000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-370000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19888000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19888000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-252000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-252000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-252000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-6000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1609000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1603000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1603000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18537000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31242000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31242000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,236000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,250000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5848000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1758000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23150000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23150000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-303000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-56115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56418000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56418000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,139000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1620000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1759000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1759000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77809000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33445000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33445000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,238000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,166000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5355000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4810000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32351000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32351000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-834000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23491000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22657000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22657000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2530000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2530000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2530000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7164000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:16:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1077000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19638000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18561000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18561000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,251000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2225000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2476000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2476000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6073000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48509000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48509000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,304000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,197000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7511000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4382000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36115000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-535000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43318000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12700000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31153000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31153000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,50000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,965000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50965000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50965000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16303000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,622000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47963000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47963000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,306000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,234000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7268000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1634000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38521000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38521000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-689000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4811000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4811000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,520000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,964000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1484000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1484000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32226000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50329000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50329000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,329000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,185000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8026000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8779000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50581000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50581000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-938000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69374000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25395000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44917000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44917000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,163747000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1850000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165597000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165597000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,70099000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:16:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42799000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42799000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,412000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,21000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8150000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2173000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32030000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32030000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-486000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24402000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27298000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2410000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2410000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,576000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,808000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23616000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23616000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53236000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,789000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41866000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7464000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6648000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40540000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40540000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,5000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,13000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70591000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,70609000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,70609000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5178000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5178000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5178000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35247000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62490000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62490000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,385000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,184000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6937000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7835000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-47149000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-47149000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1134000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27794000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,65000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8499000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20364000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20364000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,142945000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,146572000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,146572000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,79059000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52265000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52265000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,381000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7701000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17529000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61713000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61713000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-904000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39388000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40292000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40292000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-205000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4202000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3997000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3997000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-98008000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:40:05+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38670000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38670000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,330000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-435000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7824000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29778000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-60729000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-60729000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1334000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118497000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-97331000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-97331000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,205000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,363775000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6439000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,370419000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,370419000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,212359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38346000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38346000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,382000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-830000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8050000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5132000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35876000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35876000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3458000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-242497000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96700000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-149255000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-149255000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5130000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19869000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19869000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-205000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,183000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49559000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49559000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,420000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1256000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9893000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7015000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33487000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33487000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3475000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-96722000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,25000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,108500000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8328000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,531000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2530000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3061000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3061000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22098000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63012000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63012000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,467000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17973000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3342000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49024000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49024000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2136000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-127763000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,164009000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6539000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6539000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6539000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 09:16:32+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8375000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50222000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50222000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,492000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-820000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12734000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14708000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23108000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23108000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2163000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76595000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,120597000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41839000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41839000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1170000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9661000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10831000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10846000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29577000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33595000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33595000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,521000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-554000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9730000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1573000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25471000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25471000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1048000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-83221000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,110800000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28627000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4039000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3929000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3914000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7070000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57920000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57920000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,564000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-196000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11135000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19440000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26977000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26977000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3903000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-189456000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67000000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-126359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-126359000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,110000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,163090000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1926000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165126000.0
Heron Therapeutics Inc,HRTX,549300DR2I1DOPD2IX53,0000818033,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11790000.0
